Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice.
Boesch-Saadatmandi
Christine
C
Institute of Human Nutrition and Food Science, Christian-Albrechts-University, Kiel, Germany.
Niering
Julia
J
Minihane
Anne Marie
AM
Wiswedel
Ingrid
I
Gardeman
Andreas
A
Wolffram
Siegfried
S
Rimbach
Gerald
G
D000818:Animals; D053318:Apolipoprotein E3 / Q000235:genetics; D053327:Apolipoprotein E4 / Q000235:genetics; D001057:Apolipoproteins E / Q000235:genetics*; D043303:Aryldialkylphosphatase / Q000235:genetics / Q000378:metabolism*; D019587:Dietary Supplements; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D005838:Genotype; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D047495:PPAR gamma / Q000378:metabolism; D011794:Quercetin / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D000683:Serum Amyloid P-Component / Q000378:metabolism
D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D047495:PPAR gamma; D012333:RNA, Messenger; D000683:Serum Amyloid P-Component; D011794:Quercetin; D043303:Aryldialkylphosphatase